Gelatin capsules dominate the empty capsules market but face competition from vegetarian and cellulose-based alternatives due to the growing demand for plant-based and vegan products. The pharmaceutical sector is the largest end-user, driven by drug development and rising healthcare spending. The nutraceutical and dietary supplements industry heavily relies on empty capsules for encapsulating various supplements. Empty capsules are preferred for solid dosage forms, ensuring precise dosage and convenient administration, making them a popular choice in the pharmaceutical and nutraceutical sectors.
According to Data Bridge Market Research, the Empty Capsules Market is valued at USD 2,587.61 million in 2021 and is further estimated to reach USD 5,006.54 million by 2029, and is expected to grow at a CAGR of 8.4% and at during the forecast period of 2022-2029.
"Growing pharmaceutical industry surge market demand"
The growing pharmaceutical industry is a significant driver for the empty capsules market. With an aging population and increased healthcare spending, there is a rising demand for effective drug delivery systems. Empty capsules play a crucial role in encapsulating various drugs, ensuring accurate dosage and efficient delivery. As pharmaceutical companies develop new medications and formulations, the demand for empty capsules is expected to increase, supporting the growth of the market in meeting the needs of the expanding pharmaceutical sector.
What restraints the growth of the empty capsules market?
"Rising raw material costs can impede the market growth”
The empty capsules market faces the restraint of rising raw material costs. Fluctuations in the prices of materials such as gelatin or vegetarian alternatives used in capsule production can pose challenges for manufacturers. Increased raw material costs can directly impact profit margins and pricing strategies, making it difficult for manufacturers to maintain competitiveness. This constraint can limit market growth as manufacturers may struggle to pass on the increased costs to consumers while maintaining profitability.
Segmentation: Global Empty Capsules Market
The empty capsules market is segmented on the basis of type, functionality, application, and end user.
- On the basis of type, the empty capsules market is segmented into gelatine capsules and non-gelatine capsules.
- On the basis of functionality, the empty capsules market is segmented into immediate-release capsules, sustained-release capsules, and delayed-release capsules.
- On the basis of application, the empty capsules market is segmented into antibiotic and antibacterial drugs, dietary supplement, antacid and antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough and cold drugs, and other applications.
- On the basis of end user, the empty capsules market is segmented into pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories.
Regional Insights: North America dominates the global empty capsules market
North America's dominance in the empty capsules market is driven by increased investment in research and development activities for pharmaceutical drugs. The region's strong focus on drug innovation and development, coupled with a rising prevalence of diabetes, fuels the demand for empty capsules as an efficient drug delivery system. The forecast period is expected to grow further in the North American empty capsules market due to the continuous advancements in pharmaceutical research and the increasing demand for diabetic medications.
Asia-Pacific is poised to experience substantial growth in the empty capsules market driven by a growing patient pool in the region. The rising population and increasing healthcare expenditure contribute to the demand for pharmaceuticals and nutraceuticals, thereby driving the need for empty capsules as drug delivery systems. Additionally, investments in healthcare infrastructure and advancements in healthcare facilities further bolster the market growth of empty capsules in the Asia-Pacific region in the foreseeable future.
To know more about the study, visit, https://www.databridgemarketresearch.com/reports/global-empty-capsules-market
Recent Developments in the Global Empty Capsules Market
- In 2021, In response to the rising demand for capsules without titanium dioxide, Qualicaps Europe increased the variety of products in its product line.
The Prominent Key Players Operating in the Global Empty Capsules Market Include:
- ACG. (India)
- CapsCanada (Canada)
- Bright Pharma Caps (U.S.)
- Lonza (Switzerland)
- SavoiurCaps (India)
- Comed Chemicals Limited. (India)
- NATURAL CAPSULES LIMITED (India)
- Wuhan Carma Technology Co., Ltd. (China)
- Goerlich Pharma GmbH (Germany)
- NecLife Lifesciences Ltd (India)
- HealthCaps India Ltd. (India)
- Erawat Pharma Limited. (India)
- QUALICAPS (U.S.)
- SUHEUNG co., ltd. (South Korea)
- Fortcaps. (India)
- SNAIL PHARMA INDUSTRY. (China)
- Roxlor (U.S.)
- Sunil Healthcare Limited. (India)
- H & CARE Incorp. (India)
- SHAOXING KANGKE CAPSULE CO.,LTD (China)
Above are the key players covered in the report, to know about more and exhaustive list of empty capsules market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Empty Capsules Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
